Page last updated: 2024-11-04

terfenadine and Basophilic Leukemia, Acute

terfenadine has been researched along with Basophilic Leukemia, Acute in 1 studies

Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Passante, E1
Ehrhardt, C1
Sheridan, H1
Frankish, N1

Other Studies

1 other study available for terfenadine and Basophilic Leukemia, Acute

ArticleYear
In vitro inhibition of rat basophilic leukaemia mast cell (RBL-2H3) degranulation by novel indane compounds.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2008, Volume: 57 Suppl 1

    Topics: Animals; Antioxidants; beta-N-Acetylhexosaminidases; Cell Degranulation; Cell Line; Dose-Response Re

2008